XTX Topco’s Foghorn Therapeutics FHTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$39.4K Buy
+11,043
New +$58.2K ﹤0.01% 3579
2026
Q1
– Sell
-15,662
Closed -$84.6K – 3984
2025
Q4
$84.6K Buy
+15,662
New +$71K ﹤0.01% 2679
2024
Q4
– Sell
-10,900
Closed -$101K – 2469
2024
Q3
$101K Buy
+10,900
New +$78.9K 0.01% 1604
2024
Q2
– Sell
-13,448
Closed -$90.2K – 2051
2024
Q1
$90.2K Buy
+13,448
New +$74.7K 0.01% 1383
2022
Q3
– Sell
-11,436
Closed -$156K – 1179
2022
Q2
$156K Buy
+11,436
New +$148K 0.06% 532

Other funds holding FHTX

XTX Topco's FHTX Position: Q3 2026 in Review

XTX Topco opened a new position in Foghorn Therapeutics (FHTX) in Q3 2026: 11,043 shares worth $39.4K. The stake represents ﹤0.01% of the portfolio and ranks #3579 among its holdings. This is a return to the name: XTX Topco previously reported a position in FHTX as recently as Q4 2025.

XTX Topco first reported a position in FHTX in Q2 2022 and has held it in 5 quarters since. The position peaked at $156K in Q2 2022. 122 funds tracked by Wall St. Rank hold FHTX as of Q3 2026.

  • XTX Topco held 11,043 shares of Foghorn Therapeutics worth $39.4K as of Q3 2026.
  • Foghorn Therapeutics was a new XTX Topco position in Q3 2026.
  • Foghorn Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q3 2026, its #3579 holding.
  • XTX Topco first reported a position in Foghorn Therapeutics in Q2 2022 and has held it in 5 quarters since.
  • XTX Topco's Foghorn Therapeutics position peaked at $156K in Q2 2022.
  • 122 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q3 2026.

Based on XTX Topco's 13F filing for Q3 2026, filed 16 Nov 2026.